Market by Gender, End-user, and Country | Forecast 2021-2028
Triton’s research report suggests the infertility testing and treatment market in the Middle East and Africa is likely to witness growth at a compound annual growth rate of 9.43% during the years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered for analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
In
the region, IVF is a widely accepted infertility treatment in the clinical
industry. The government initiatives for developing the healthcare
infrastructure, rising lifestyle and hormonal disorders, and declining rates of
pregnancies are supporting the growth of IVF treatments across the region’s
nations. This will ultimately contribute to the growth of the infertility
testing and treatment market across the region.
In
the United Arab Emirates, there has been a major decline in fertility rates,
owing to high levels of diabetes and polycystic ovary syndrome. These
conditions create a hormonal imbalance, making conceiving a major challenge.
Although there are strict laws against surrogacy, the country permits fertility
treatments under sharia law. Moreover, the government is encouraging IVF
treatment owing to the rise in infertility rates. Hence, the supportive
government laws are estimated to supplement the growth of the infertility
testing and treatment market across the UAE.
Furthermore,
the growing demand for medical care has made countries like Turkey adopt
several policies to encourage and subsidize the international flow of patients.
The country is considered to be among the popular medical tourist destinations
due to the provision of offering high-level medical facilities at relatively
low costs. Therefore, the developing medical sector is likely to open new
avenues for the infertility testing and treatment market.
Ferring
Pharmaceuticals is a specialty biopharmaceutical group providing innovative
products in the fields of reproductive medicine and women’s health, urology,
and gastroenterology. Its product line includes Endometrin, a vaginal insert
containing hormones for patients requiring high progesterone levels. Ferring
has operations around various regions, such as Europe and the Middle East and
Africa region.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY INSIGHTS
2.1.1. GROWING
DEMAND FOR LOW-COST PROCEDURES
2.1.2. INCREASING
ACCEPTANCE OF DONOR EGGS
2.1.3. USE OF
AI INCREASES THE SUCCESS OF IVF TREATMENT
2.2. IMPACT
OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. TREATMENT
OPTIONS
2.4.2. QUALITY
OF MEDICAL PROCEDURES
2.4.3. PRICE
OF TREATMENTS
2.4.4. SHIFT
TOWARDS MEDICAL TOURISM
2.4.5. REIMBURSEMENT
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.6.1. RAW
MATERIAL PROCUREMENT
2.6.2. MANUFACTURING
2.6.3. SUPPLY
LOGISTICS
2.6.4. DISTRIBUTION
CHANNELS
2.6.5. END-USERS
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
& PARTNERSHIPS
2.8.2. ACQUISITIONS
& MERGERS
2.8.3. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. GROWTH
IN STRESS AND LIFESTYLE DISORDERS
2.9.2. RISING
TREND IN DELAYED MARRIAGES AND PREGNANCIES
2.9.3. IMPROVEMENTS
IN TREATMENTS
2.9.4. GOVERNMENT
SUPPORT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST
2.10.2. SOCIAL
TABOO PERTAINING TO INFERTILITY
2.10.3. RISKS
ASSOCIATED WITH TREATMENTS
2.11. MARKET
OPPORTUNITIES
2.11.1. TECHNOLOGY
ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY
2.11.2. ADVANCES
IN EMBRYO BIOPSY AND GENETIC SCREENING
3. MIDDLE
EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER
3.1. MALE
3.1.1. MALE
INFERTILITY TESTING
3.1.1.1. DNA
FRAGMENTATION
3.1.1.2. OXIDATIVE
STRESS ANALYSIS
3.1.1.3. SPERM
PENETRATION ASSAY
3.1.1.4. COMPUTER-ASSISTED
SEMEN ANALYSIS (CASA)
3.1.1.5. SPERM
AGGLUTINATION
3.1.1.6. MICROSCOPIC
EXAMINATION
3.1.1.7. OTHERS
3.1.2. MALE
INFERTILITY TREATMENT
3.1.2.1. MEDICATION
3.1.2.2. ASSISTED
REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
3.2. FEMALE
3.2.1. FEMALE
INFERTILITY TESTING
3.2.1.1. OVULATION
TESTING
3.2.1.2. HYSTEROSALPINGOGRAPHY
3.2.1.3. LAPAROSCOPY
3.2.1.4. TRANSVAGINAL
ULTRASOUND
3.2.1.5. OVARIAN
RESERVE TESTING
3.2.1.6. HORMONAL
LEVEL TESTING
3.2.1.7. OTHERS
3.2.2. FEMALE
INFERTILITY TREATMENT
3.2.2.1. IVF
WITH ICSI
3.2.2.2. IUI
3.2.2.3. IVF
WITHOUT ICSI
3.2.2.4. SURROGACY
3.2.2.5. OTHERS
4. MIDDLE
EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER
4.1. FERTILITY
AND SURGICAL CENTERS
4.2. HOSPITALS
& RESEARCH LABORATORIES
4.3. CRYOBANKS
5. MIDDLE
EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK
5.1. UNITED
ARAB EMIRATES
5.2. TURKEY
5.3. SAUDI
ARABIA
5.4. SOUTH
AFRICA
5.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. ADORFEM
6.2. BANGKOK
IVF CENTER
6.3. COOK
MEDICAL INC
6.4. COOPER
SURGICAL
6.5. CREATE
FERTILITY CENTRE
6.6. EMD
GROUP (MERCK KGAA)
6.7. ENDO
INTERNATIONAL PLC
6.8. FERRING
PHARMACEUTICALS
6.9. HALOTECH
DNA
6.10. GENEA
LTD
6.11. FUJIFILM
IRVINE SCIENTIFIC
6.12. VITROLIFE
AB
6.13. LABOTECT
GMBH
6.14. OLYMPUS
CORPORATION
6.15. PROGYNY
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN
$ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS
& PARTNERSHIPS
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES
TABLE 7: AVERAGE COST
COMPARISON OF INFERTILITY TREATMENTS
TABLE 8: MIDDLE EAST AND AFRICA
INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $
MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 11: ROS AND CONS OF DNA
SHARING METHODS
TABLE 12: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $
MILLION)
TABLE 14: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
TABLE 15: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY
TREATMENT, 2021-2028 (IN $ MILLION)
TABLE 16: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $
MILLION)
TABLE 17: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN
$ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN
%)
FIGURE 5: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $
MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN
%)
FIGURE 7: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING,
2020 & 2028 (IN %)
FIGURE 9: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION,
2021-2028 (IN $ MILLION)
FIGURE 10: CAUSES OF SPERM DNA
FRAGMENTATION
FIGURE 11: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS,
2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY,
2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN
ANALYSIS (CASA), 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION,
2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION,
2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $
MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT,
2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT,
2020 & 2028 (IN %)
FIGURE 19: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $
MILLION)
FIGURE 20: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE
TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $
MILLION)
FIGURE 22: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN
%)
FIGURE 23: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2021-2028 (IN $ MILLION)
FIGURE 24: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING,
2020 & 2028 (IN %)
FIGURE 25: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING,
2021-2028 (IN $ MILLION)
FIGURE 26: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY,
2021-2028 (IN $ MILLION)
FIGURE 27: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN
$ MILLION)
FIGURE 28: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND,
2021-2028 (IN $ MILLION)
FIGURE 29: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING,
2021-2028 (IN $ MILLION)
FIGURE 30: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING,
2021-2028 (IN $ MILLION)
FIGURE 31: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $
MILLION)
FIGURE 32: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY
TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 33: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY
TREATMENT, 2020 & 2028 (IN %)
FIGURE 34: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028
(IN $ MILLION)
FIGURE 35: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $
MILLION)
FIGURE 36: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028
(IN $ MILLION)
FIGURE 37: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $
MILLION)
FIGURE 38: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $
MILLION)
FIGURE 39: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028
(IN %)
FIGURE 40: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL
CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 41: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH
LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 42: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $
MILLION)
FIGURE 43: MIDDLE EAST AND
AFRICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 &
2028 (IN %)
FIGURE 44: UNITED ARAB
EMIRATES INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: TURKEY INFERTILITY
TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: SAUDI ARABIA
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: SOUTH AFRICA
INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: REST OF MIDDLE EAST
& AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)